CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study

Cancer. 1973 Jul;32(1):38-43. doi: 10.1002/1097-0142(197307)32:1<38::aid-cncr2820320105>3.0.co;2-i.
No abstract available

MeSH terms

  • Adenocarcinoma / drug therapy
  • Antiemetics / therapeutic use
  • Bone Marrow / drug effects
  • Capsules
  • Carcinoma, Squamous Cell / drug therapy
  • Chemical and Drug Induced Liver Injury
  • Cyclohexanes*
  • Evaluation Studies as Topic
  • Humans
  • Nausea / chemically induced
  • Neoplasms / drug therapy*
  • Nitrosourea Compounds / administration & dosage
  • Nitrosourea Compounds / adverse effects
  • Nitrosourea Compounds / therapeutic use*
  • Vomiting / chemically induced

Substances

  • Antiemetics
  • Capsules
  • Cyclohexanes
  • Nitrosourea Compounds